Constellium Climbs Despite Q4 Loss

Cyclacel Pharmaceuticals Inc. NASDAQ:CYCC, Pendrell Corp. NASDAQ:PCO and Constellium NV NYSE:CSTM are making notable climbs this Thursday. EXCO Resources Inc. NYSE:XCO, Lumos Networks Corp. NASDAQ:LMOS and Organovo Holdings Inc. NYSEMKT:ONVO are taking tumbles.

Sign up for our free newsletter

Constellium

 

Pendrell Rebounds

Cyclacel Pharmaceuticals Inc. was up +12.83% about an hour and a half ahead of market close today. The stock - a Wilbur Ross holding - is still down more than -70% over the past year.

Pendrell Corporation gained +6.93% this Thursday, rebounding after hitting a new 52-week low just days ago. The intellectual property investment and advisory company, a Farallon Capital pick, is down -21% year-to-date.

Constellium NV surged +6.4% in the wake of its earnings report. The Netherlands-based company reported a fourth quarter loss of $18.1 million - something that apparently didn't have Wall Street too nervous. George Soros has a stake in the firm, the share price of which has rallied about +22% in 2015.

EXCO Resources Plummets

EXCO Resources tumbled -9.94% today and looks weak on high trading volume. The company has had a rough to in recent weeks and in late February announced plans to cut its workforce by 15% and slash its capital budget by 35% in 2015. The billionaire taking a hit on this one: Wilbur Ross.

Lumos Networks dipped -7.09%, putting its five-day loss at about -10%. George Soros has a stake in the company.

Organovo Holdings fell -6.74% today and is down -40% YTD. Chase Coleman's Tiger Global has a stake in the development-stage company.

Screen Shot 2015-02-23 at 3.00.26 PM
Download PDF

The post Constellium Climbs Despite Q4 Loss appeared first on ValueWalk. Like this article? Sign up for our free newsletter to get articles delivered to your inbox

-By iBillionaire

More from Stocks

General Electric Slips as Cowen Suggests Culp Needs to Take Action

General Electric Slips as Cowen Suggests Culp Needs to Take Action

Investors Face Growing Opportunities and Challenges in Cannabis

Investors Face Growing Opportunities and Challenges in Cannabis

J.C. Penney Shares Have Plunged 64% Since Quant Ratings Downgrade

J.C. Penney Shares Have Plunged 64% Since Quant Ratings Downgrade

The 'Fear of Missing Out' Is Missing

The 'Fear of Missing Out' Is Missing

Bye, Bye, Bye Sears: The Week Ahead

Bye, Bye, Bye Sears: The Week Ahead